Abstract:Introduction: Despite the importance of gut microbiota in human cardiometabolic health, the associations between circulating levels of gut microbiota-related metabolites and incident coronary heart disease (CHD) remain largely unexplored. Hypothesis: Certain circulating microbial metabolites are associated with incident CHD. Methods: This is a multi-stage and multiethnic metabolomics study. We first conducted a global, semi-quantitative assay for discovery among 900 incident CHD cases and 900 age-/sex-/race-matched controls (300 pairs of Black Americans, White Americans, and Chinese adults, respectively) selected from the Southern Community Cohort Study and Shanghai Men’s and Women’s Health Studies. We focused on 226 metabolites that were potentially related to gut microbiota and applied conditional logistic regression to estimate odds ratios (ORs) of CHD associated with a 1-SD increase of log-transformed metabolites adjusting for traditional CHD risk factors. Then, an in-silico validation was conducted using existing metabolites data of 9,264 participants from the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities Study. Results: In the discovery stage, we identified 73 named microbial metabolites related to incident CHD risk with a false discovery rate<0.10 or nominal p 1.5 or <0.5). These metabolites were from super pathways of amino acids (n=28), lipids (n=24), nucleotides (n=6), carbohydrates (n=4), energy (n=4), xenobiotics (n=4), and cofactors/vitamins (n=3). Of them, 61 metabolites were available for the in-silico validation, and 30 showed a significant association ( p <0.05) with the same direction as the discovery results. After further adjustments for established CHD risk factors (e.g., glucose and LDL-cholesterol), 25 metabolites remained significant. A 14%-48% increased risk was observed for N-acetylglutamate (OR=1.48), sphingomyelin (1.42), imidazole propionate (1.37), hypoxanthine (1.29), guaiacol sulfate (1.28), glutamate (1.22), 2-hydroxyphenylacetate (1.20), 3-hydroxybutyrate (1.19), 3-hydroxy-2-ethylpropionate (1.17), 1-methyl-4-imidazoleacetate (1.16), urea (1.16), urate (1.16), 4-hydroxyphenylacetate (1.15), choline (1.15), isoleucine (1.14), and glycerol (1.14). Meanwhile, a significant inverse association was found for taurine (OR=0.64), asparagine (0.75), serotonin (0.78), histidine (0.79), threonine (0.81), glutamine (0.83), glycine (0.84), oxalate (0.85), and N-methylproline (0.89). Conclusions: Among ethnically and geographically diverse populations, we identified and validated some circulating gut microbiota-related metabolites as potential novel biomarkers for incident CHD. Targeted quantitative assays to confirm these results are ongoing, which are essential to inform potential clinical utility.

Mapping the gut microecological multi-omics signatures to serum metabolome and their impact on cardiometabolic health in elderly adults

Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis

Gut Microbial Features and Circulating Metabolomic Signatures of Frailty in Older Adults

Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk

Contribution of Diet to Gut Microbiota and Related Host Cardiometabolic Health: Diet-Gut Interaction in Human Health.

Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health.

The Temporal Dynamics of the Gut Mycobiome and Its Association with Cardiometabolic Health in a Nationwide Cohort of 12,641 Chinese Adults

The gut microbiome in subclinical atherosclerosis: a population-based multiphenotype analysis

Diet Mediate the Impact of Host Habitat on Gut Microbiome and Influence Clinical Indexes by Modulating Gut Microbes and Serum Metabolites

Abstract MP23: Circulating Gut Microbiota-Related Metabolites and Risk of Coronary Heart Disease: A Prospective, Multiethnic, Metabolomic Study

IDDF2020-ABS-0141 the Gut Microbiome and Serum Metabolome Orchestrate Healthy Aging and Longevity with Novel Implications for Renal Function

Impact of lifestyle on carotid vascular pathogenesis is mediated by the gut microbiome: A population-based analysis of gut microbiome in Chinese elderly

Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease

Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites

Gut microbiota signatures of long-term and short-term plant-based dietary pattern and cardiometabolic health: a prospective cohort study

Symbiotic gut microbes modulate human metabolic phenotypes

Disease Trends in a Young Chinese Cohort According to Fecal Metagenome and Plasma Metabolites

Gut microbial genomes with paired isolates from China illustrate probiotic and cardiometabolic effects

Mapping the gut microbial structural variations in healthy aging within the Chinese population

Integrated metagenome and metabolome analyses of blood pressure studies in early postmenopausal Chinese women

Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk